FDA acts to expand use of treatment for COVID-19 patients with mild-to-moderate disease
The healthy-living took action Friday to expand the use of the antiviral remdesivir drug Veklury to certain non-hospitalized adults and healthy-living for the treatment of mild-to-moderate infectious-disease. Previously, the use of the Gilead Sciences Inc. drug was limited to those requiring hospitalization. “On the heels of the FDA’s recent authorization of two oral antiviral drugs,…